Back to Market Feed

Product Information

ARISTADA INITIO ER 675 MG/2.4 is a brand product labeled by Alkermes, Inc., priced at $1026.9112 per ML under NDC 65757050003. Its NADAC has been published 96 times since Oct 23, 2024.

FDA first approved this application on Jun 29, 2018.

ARISTADA INITIO ER 675 MG/2.4

aripiprazole lauroxil
$1026.9112per ML

Strength

675 mg/2.4mL

Manufacturer

Alkermes, Inc.

NDC

65757050003

Classification

Brand

Dosage Form

INJECTION, SUSPENSION, EXTENDED RELEASE

Route

INTRAMUSCULAR

Effective Date

1/1/2026

Active Ingredients

ARIPIPRAZOLE LAUROXIL

Approval Type

New Drug (NDA)

FDA Application

NDA209830

FDA Approved

6/29/2018

On Market Since

6/29/2018

Pharmacological Classes

Atypical Antipsychotic

Price Statistics

The NADAC for ARISTADA INITIO ER 675 MG/2.4 has been published 96 times since Oct 23, 2024, and over the history we have for it it has risen 9.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1026.9112 per ML
All-time high$1026.9112 (Aug 19, 2026)
All-time low$936.4222 (Oct 23, 2024)
52-week high$1026.9112
52-week low$967.7065
Median price$967.7065
Average price$983.9985
Largest weekly change+6.0% (Jan 14, 2026)
Weeks tracked96
Tracking sinceOct 23, 2024

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

+6.1%

3Y

N/A

5Y

N/A

All

+9.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the aripiprazole lauroxil market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

SEROQUEL 25 MG TABLET
Brand
00310027510•AstraZeneca Pharmaceuticals LP
$3.7108
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030201•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 0.5 MG TABLET
Brand
50458030206•Janssen Pharmaceuticals Inc.
$4.3842
per EA
RISPERDAL 1 MG TABLET
Brand
50458030001•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG TABLET
Brand
50458030006•Janssen Pharmaceuticals Inc.
$4.6907
per EA
RISPERDAL 1 MG/ML SOLUTION
Brand
50458030503•Janssen Pharmaceuticals Inc.
$5.2820
per ML
SEROQUEL 50 MG TABLET
Brand
00310027810•AstraZeneca Pharmaceuticals LP
$6.0917
per EA
SEROQUEL 100 MG TABLET
Brand
00310027110•AstraZeneca Pharmaceuticals LP
$6.3807
per EA
CLOZARIL 25 MG TABLET
Brand
69809012605•HLS Therapeutics (USA), Inc.
$6.5446
per EA
SEROQUEL XR 50 MG TABLET
Brand
00310028060•AstraZeneca Pharmaceuticals LP
$7.7675
per EA

Frequently asked questions

What is the NADAC price of ARISTADA INITIO ER 675 MG/2.4?

The current National Average Drug Acquisition Cost (NADAC) for ARISTADA INITIO ER 675 MG/2.4, manufactured by Alkermes, Inc., is $1026.9112 per ML (NDC 65757050003), effective Aug 19, 2026.

How has the price of ARISTADA INITIO ER 675 MG/2.4 changed over time?

Over the history we have for it, the NADAC for ARISTADA INITIO ER 675 MG/2.4 has risen 9.7%. It has been tracked across 96 weekly CMS publications since Oct 23, 2024.

What are the highest and lowest recorded NADAC prices for ARISTADA INITIO ER 675 MG/2.4?

Since Oct 23, 2024, the NADAC for ARISTADA INITIO ER 675 MG/2.4 has ranged from a low of $936.4222 (Oct 23, 2024) to a high of $1026.9112 (Aug 19, 2026), with a median of $967.7065 per ML.

Are there cheaper alternatives to ARISTADA INITIO ER 675 MG/2.4?

No other NADAC-published product currently shares the active ingredient and strength of ARISTADA INITIO ER 675 MG/2.4 in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures ARISTADA INITIO ER 675 MG/2.4?

ARISTADA INITIO ER 675 MG/2.4 (NDC 65757050003) is labeled by Alkermes, Inc., and CMS classifies it as a brand product.